Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer - von der Maase, H; Sengelov, L; Roberts, J T (J Clin Oncol, 2005)
et al.